IDL Biotech continues to expand in Africa. Today, IDL Biotech has signed a distributor agreement with Roi Scientific Ltd covering Rwanda, South Sudan and Somalia. The agreement covers the sale of TUBEX® TF.
Since its launch in Africa, the company has focused on finding the right partners for distribution. IDL Biotech has previously announced that agreements have been signed with distributors in Uganda, Zimbabwe and Kenya. Now the company has also signed a distribution agreement
with Roi Scientific Ltd for distribution in Rwanda, South Sudan and Somalia. The agreement covers the sale of the company’s rapid test TUBEX® TF for typhoid fever.
Read the press release here (Swedish)
Den Oberoende Budkommittén för IDL Biotech AB (”IDL” eller ”Bolaget”) rekommenderar aktieägarna att acceptera det offentliga uppköpserbjudandet om 0,63 aktier i AroCell AB (publ) (”AroCell” eller ”Budgivaren”) per aktie i IDL som lämnats av Budgivaren den 10 maj 2021.
IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company delivers TUBEX® TF.
